IXI raises $36.5M from Amazon and others to carry autofocus to prescription glasses

Blink and also you’ll miss it: A startup out of Finland is taking a brand new take a look at the marketplace for prescription eyewear. Tapping into improvements in eye-tracking and liquid crystal lens expertise, IXI is constructing low-power glasses that may invisibly and robotically modify to account for a wearer’s presbyopia (far-sightedness).

4 years into its life, Helsinki-based IXI emerged from stealth on Tuesday, asserting that it’s raised a complete of $36.5 million from an inventory of buyers that embrace the Amazon Alexa Fund, to work towards its first business product. 

London-based VC agency Plural is main the newest tranche of Sequence A funding, with participation from Tesi, byFounders, Heartcore, Eurazeo, FOV Ventures, Tiny Supercomputer, and current buyers. The startup’s earlier buyers, along with the Amazon Alexa Fund, embrace Maki.vc, First Fellow, firstminute capital, John Lindfors, Illusian (a household workplace of European founders much like ICONIQ within the U.S.), and Bragiel Brothers. 

“Eyewear is the final nice frontier,” mentioned CEO Niko Eiden, who co-founded the corporate with chief algorithm officer Ville Miettinen. It is usually probably a profitable frontier: IXI cites estimates that put the present marketplace for eyewear at over $200 billion and rising at a price of over 8%, quicker than smartwatches and smartphones. 

IXI (previously referred to as Pixieray) is based and staffed by a crew that initially labored on groundbreaking cell expertise at Nokia that finally was utilized in HoloLens XR headgear at Microsoft (which had acquired a big a part of Nokia). Later, the co-founders began Varjo, a mixed-reality headset developer that targets the enterprise market and has raised greater than $200 million in enterprise funding from buyers like Atomico, EQT, and Foxconn.

VR and combined actuality, Eiden mentioned, “continues to be tremendous fascinating … but it surely’s a very laborious house to be in as a result of there isn’t any market, and the volumes usually are not there.” 

Varjo, he added, did a “nice job” of determining how one can pivot into the area of interest of business and enterprise purposes.

However even with large corporations like Meta, Apple, Sony, and Microsoft pursuing {hardware} within the VR house, it’s been a battle thus far to seek out something like hockey stick development for the expertise.

Gross sales have steadily elevated, however they’re nonetheless within the single-digit billions, which sounds large however is definitely small for client electronics, a disappointment to the startups and hyperscaler tech giants which have poured a whole lot of hundreds of thousands of {dollars} of funding into the house. Tellingly, Microsoft discontinued HoloLens final October and has no plans for a successor.

In IXI’s view, AR and VR pursuits additionally go away rather a lot on the desk when it comes to what is being addressed within the space of eyewear.

Not one of the earlier efforts have appeared intently (pun!) at how and if they will deal with eyewear as a medical system, which is what prescription glasses are.

“There actually aren’t that many making an attempt to make use of expertise to truly repair eyesight, and that’s type of the cool half for us,” mentioned Eiden.

Certainly, you’ll be able to’t use the IXI glasses to verify your electronic mail, publish to Instagram, seek for a restaurant, play a sport recognizing cute creatures on the road, or get more information on the place to purchase the sneakers you’ve noticed on somebody’s ft. It’s nearly seeing extra clearly. 

IXI has filed and utilized for numerous patents round its invisibly sensible eyewear. Eiden and his COO Jussi Havu declined to speak about too many specifics of the glasses, however in a nutshell, it makes use of a really small system constructed into the body to trace your eyes and correspond with liquid crystal lenses that robotically modify to assist the wearer see the gadgets in focus. 

The worth factors, Havu mentioned, are nonetheless in flux, as there isn’t any product but to promote. IXI has executed some market analysis on willingness to pay, and at present the pondering is that these can be priced not like bifocals (which you should buy in retailers for below $10), however like client electronics, comparable with “a high-end iPhone” at first. “Not extremely luxurious, nonetheless mass market,” he added.

The use case, they are saying, is to make it simpler for various segments of bad-vision customers: for many who must have glasses to see up shut and much away, to have just one pair of glasses as an alternative of carrying a number of pairs of glasses; for many who already use varifocals however have discovered these progressive lenses clumsy to make use of and put on; and, it appears, even for many who have previously opted for laser eye surgical procedure to appropriate their imaginative and prescient.

Early adopters of the process many years in the past, Eiden mentioned, at the moment are seeing the “bounce again” of their laser surgical procedure. Even after they can see lengthy distances with out glasses, they nonetheless require bifocals to learn. Eigen is aware of this firsthand, he advised me: He’s a type of early adopters.

For all the above, the assumption is that there can be a market of people that will need to have the power to regulate what and the way they will see with out having to consider it.

IXI estimates the battery life on its glasses to be about two days. The lenses themselves can be constructed with near-sighted prescriptions (to see issues far-off), so even when the battery dies if you are, say, driving, you’ll nonetheless be capable to see clearly. Nonetheless, it seems like should you’re studying and it runs out of juice mid-page, you’ll be out of luck. 

IXI isn’t the one firm pursuing the concept of “autofocus” eyewear, though these already in the marketplace look considerably much less seamless than what IXI needs to construct. Elcyo, out of Japan, and Laclarée, in France, each additionally envision eyewear that seem like regular glasses however gives autofocus to let customers see issues clearly, however neither have but launched a product. Laclarée had plans to launch its first product in 2022, however its goalpost is now 2026 — a measure of how difficult it truly is to get such concepts off the bottom.

One other Japanese firm, Vixion, has launched autofocus eyewear, however its gadgets embrace bodily objects that seem like small digital camera lenses embedded in them. 

IXI’s pedigree and monitor report of execution are two the reason why buyers are eager on seeing it take a crack on the downside. 

Eiden mentioned Amazon was fast to spend money on the product partly as a result of he already knew Jeff Bezos from one in every of his earlier corporations. He didn’t disclose which firm that was, however he mentioned there have been discussions about Amazon probably working with the expertise he and his groups had constructed (maybe it had appeared one thing to do with with Varjo?).

Finally, these talks by no means got here to something, but it surely made for a really fast “sure” when it got here to investing in IXI, he mentioned. 

“The concept of bringing on-demand vision-correction to the place it’s wanted in Rx eyewear is compelling,” Paul Bernard, who heads the Alexa Fund, advised TechCrunch over electronic mail, citing the clumsiness of present options.

“Auto-tuning lenses require low-power/high-performance, eye-tracking and algorithmic adjustment to liquid crystal lenses at very excessive velocity. We expect the IXI crew is effectively suited to deal with these issues given their earlier work at Varjo, the place they labored on advancing the SOTA [state of the art] in VR/XR applied sciences,” he added. 

Amazon at present sells readers (for long-sightedness) on its market, however the firm clearly sees (heh) a future the place it might do much more. 

In November 2024, it emerged, for instance, that the e-commerce big was engaged on particular glasses for supply drivers to assist them get parcels to their locations quicker. 

These supply glasses, in the event that they’re ever launched, can be extra within the realm of mixed-reality eyewear. However should you shift your consideration to Amazon’s rising enterprise in areas like pharmacy, you’ll be able to envision a possibility for the corporate to leverage economies of scale in eyewear manufacturing that would deal with each corrective imaginative and prescient and AR/VR use circumstances.

Eiden and Havu mentioned the expertise they’re constructing for IXI has been confirmed already within the labs. “Later this yr, you should have an opportunity to see the prototype,” Havu mentioned. IXI declined to say when it may need a product prepared for the market, which, along with every thing else, will want approvals to be offered as glasses. “That is simply step one,” he mentioned.

Nonetheless, with the patents and different work the startup has executed, there may be sufficient potential in IXI that’s merited investor curiosity round a really large alternative.

“Niko, Ville and the crew’s uncommon European {hardware} experience places them on the forefront of superior optics and eye-tracking developments,” Sten Tamkivi, a associate at Plural, mentioned in a press release. “They’re creating stunning, actually invisible expertise that pioneers a brand new strategy to imaginative and prescient which is able to lastly enhance human eyesight as soon as and for all. By backing IXI, we’re not simply investing in an organization, however in a future the place expertise revolutionises how we see the world.”